AI Article Synopsis

  • PTSD affects about 8% of people in the U.S., significantly impacting veterans and civilians who have experienced trauma, highlighting the need for new research on its biological aspects.
  • Studies suggest that PTSD may involve changes in stress response systems like the HPA axis and SAM system, yet few have focused on its effects on the immune system.
  • Patients with PTSD show immune changes such as increased inflammation, altered immune cell activity, and a connection between these immune alterations and the neuroendocrine changes associated with PTSD.

Article Abstract

Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2010.10.003DOI Listing

Publication Analysis

Top Keywords

patients ptsd
16
ptsd
11
posttraumatic stress
8
stress disorder
8
medical comorbidities
8
immune changes
8
changes
5
immune
5
short review
4
review psychoneuroimmunology
4

Similar Publications

Despite a varied selection of available trauma-focused evidence-based psychotherapies (TF-EBPs) for posttraumatic stress disorder (PTSD), few veterans receive a full course of an evidence-based treatment. A better understanding of and alignment with veterans' PTSD treatment goals could be one way to improve treatment engagement and adherence, consistent with veteran-oriented care within the U.S.

View Article and Find Full Text PDF

On October 7, 2023, a large-scale attack in southern Israel and the subsequent war resulted in extensive loss of life and injuries, with many individuals experiencing traumatic losses, such as family members or close friends being killed or kidnapped. This study aims to longitudinally examine its effects on mental health, specifically, clinical symptoms of anxiety, depression, and posttraumatic stress disorder (PTSD). We anticipated greater symptom severity among individuals who experienced traumatic loss, were forcibly displaced, or suffered income loss, as well as among women and members of ethnic minorities.

View Article and Find Full Text PDF

Objectives: Posttraumatic stress disorder (PTSD) may affect antiretroviral therapy (ART) response and clinical outcomes for veterans with HIV (VWH) receiving care in the Department of Veterans Affairs (VA). Objectives are to estimate the associations between PTSD and ART nonadherence, modifications, and failure; measure effect modification by number of deployments and combat exposure; and examine how these associations vary over time.

Design: In this prospective cohort study of all VWH on ART who deployed to Iraq and Afghanistan and receive care in the VA (n = 3206), patients entered at ART initiation and were censored in December 2022, totaling 22 261 person-years of follow-up.

View Article and Find Full Text PDF

Addressing Perinatal Mood and Anxiety disorders in Obstetric Settings: Results of a Cluster Randomized Controlled Trial of Two Approaches.

Am J Obstet Gynecol MFM

January 2025

University of Massachusetts Chan Medical School, Department of Obstetrics and Gynecology, Psychiatry, Pediatrics, Population and Quantitative Health Sciences; UMass Memorial Health Department of Obstetrics and Gynecology(2), Worcester, MA.

Article Synopsis
  • Mood and anxiety disorders affect one in five perinatal individuals, yet they are often not adequately treated due to various barriers in obstetric practices. To improve this situation, implementation assistance and an e-learning toolkit were developed for obstetric clinicians.
  • The main goal was to assess how these resources impacted the screening and treatment of mood and anxiety disorders compared to usual care by conducting a cluster randomized controlled trial across 13 obstetric practices in the U.S.
  • Results showed that there were no significant differences at baseline in mental health screening documentation among the groups, indicating a need for enhanced strategies in documenting and addressing these disorders effectively.
View Article and Find Full Text PDF

Experiencing a traumatic event may lead to Posttraumatic Stress Disorder (PTSD), including symptoms such as flashbacks and hyperarousal. Individuals suffering from PTSD are at increased risk of cardiovascular disease (CVD), but it is unclear why. This study assesses shared genetic liability and potential causal pathways between PTSD and CVD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!